# Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App

Study · id `cardio:ct-nct05482503` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05482503](<https://clinicaltrials.gov/study/NCT05482503>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05482503

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 673 participants.

## Technical summary

Registry record NCT05482503. Non-randomized; single masking; primary purpose diagnostic. Start 2021-04-02 (actual); primary completion 2021-09-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 673 participants (enrolled count; ClinicalTrials.gov record NCT05482503, source copy `cardio:ctgov-nct05482503-2022-08-02`, retrieved 2026-10-26)
- Started: 2021-04-02 (actual) (ClinicalTrials.gov record NCT05482503, source copy `cardio:ctgov-nct05482503-2022-08-02`, retrieved 2026-10-26)
- Primary completion: 2021-09-30 (actual) (ClinicalTrials.gov record NCT05482503, source copy `cardio:ctgov-nct05482503-2022-08-02`, retrieved 2026-10-26)
- Completion: 2021-09-30 (actual) (ClinicalTrials.gov record NCT05482503, source copy `cardio:ctgov-nct05482503-2022-08-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05482503, source copy `cardio:ctgov-nct05482503-2022-08-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05482503-2022-08-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App
- Condition: Arrhythmias, Cardiac
- Intervention (Device): 12-Lead ECG(I-lead)
- Lead sponsor: Huawei Device Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)

## Provenance

Content hash: 3e736117695dc6610abec7545cb3f1eaff867647a7a1c13633f12ba8e23599dd
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
